An expert discusses how neurokinin receptor antagonists like fezolinetant (NK3) and elinzanetant (NK1/NK3) work in the hypothalamus to reduce vasomotor symptoms, with elinzanetant showing promising skeletal benefits.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

Preconception hypoglycemia is linked to increased risks of preterm birth, low birth weight, and birth defects, a new study from China finds.

Take a quick look at everything you may have missed last month, including the latest FDA updates, top stories, and exclusive interviews.

Panelists discuss how certain patients require closer monitoring, including those with previous mental health histories, recent losses, childhood trauma, or abrupt medication cessation, while emphasizing the importance of continuing necessary psychiatric medications during pregnancy and lactation through proper risk-benefit discussions.

Panelists discuss how untreated perinatal mood disorders create cascading effects that impact breastfeeding, partner relationships, and child development, and can lead to adverse childhood experiences with long-term consequences for both mothers and children across generations.

A new review finds immediate release nifedipine offers comparable safety and efficacy to IV labetalol and hydralazine in managing severe hypertension during pregnancy.

A new study found the severity of pelvic pain in endometriosis patients affects health-related quality of life through the influence of coping mechanisms.

A new study reveals Black women have larger, more U-shaped levator hiatus dimensions than White women, highlighting potential implications for pelvic floor disorder.

Panelists discuss how younger women (18-24) most commonly use condoms and oral contraceptive pills due to factors like less frequent sex, dual protection needs, and access issues, while emphasizing that individual preferences matter more than age when counseling patients.

Panelists discuss how combined hormonal contraceptives come in three main forms (pills, patches, and rings) and provide a comprehensive overview of all available contraceptive methods including long-acting reversible contraceptives, barrier methods, and emergency contraception.

SARS-CoV-2 infection during pregnancy alters placental gene expression and increases pathology, especially when contracted in the first trimester.

Driven by economic concerns and shifting family planning trends, the US fertility rate dropped below 1.6 births per woman, despite a slight rise in total births.

In the wake of tightening abortion laws, telemedicine and advance provision of abortion pills are emerging as essential, safe, and accessible solutions for reproductive health care.

Jessica Shepherd, MD, MBA, outlines current cervical cancer screening recommendations, the potential role of HPV self-collection, and strategies to improve patient understanding and access to care.

A new meta-analysis found no significant difference in wound complications between metal staples and subcuticular sutures for post-cesarean skin closure in obese patients.

A new study finds that patient-reported screening methods are highly effective for determining medication abortion eligibility.

A new ACOG clinical guidance offers updated recommendations on umbilical cord management for preterm births based on recent evidence and analysis.

Stephanie Pearson, MD, provides some tips for ergonomics within obstetrics and gynecology.

A new study finds that infections such as chlamydia, gonorrhea, and syphilis during pregnancy significantly increase the risk of stillbirth, preterm birth, and low birth weight.

The World Health Organization’s evidence-based recommendations aim to improve care and outcomes for pregnant women with sickle cell disease.

An expert discusses how estrogen remains the most effective treatment for vasomotor symptoms while also benefiting bone density, though alternative treatments like paroxetine and fezolinetant lack bone health benefits.

An expert discusses how menopause triggers increased bone remodeling with imbalanced resorption exceeding formation, leading to progressive bone loss and potential osteoporosis that requires careful attention to optimize bone health.

"The FDA did not raise any concern regarding the general approvability of elinzanetant in its correspondence," according to an anouncement from Bayer.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.